SER Earnings

Quarterly EPS
$0.16
Q3 2024
$0.00
Q4 2024
$-0.49
Q1 2025
$-0.66
Q2 2025
$-0.45
Q3 2025
$-0.34
Q4 2025
$-0.58
Q1 2026
$-0.55
Q2 2026
Latest RevenueN/A
Latest Net Income-6356000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.550-6356000-100.0%+16.7%
Q1 2026-$0.580-6898000-18.4%
Q4 2025-$0.340-3336000
Q3 2025-$0.450-4595000-100.0%-381.3%
Q2 2025-$0.66130.0K-6462000+154.9%-208.2%
Q1 2025-$0.490-4822000-100.0%+90.9%
Q4 2024
Q3 2024$0.1614.0K1.4M
Q2 2024$0.6151.0K5.2M
Q1 2024-$5.385.0K-15015000
Serina Therapeutics (SER) — Earnings